{{Rsnum
|rsid=2804402
|Gene=ABCC2
|Chromosome=10
|position=101541583
|Orientation=minus
|GMAF=0.3572
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{PharmGKB
|RSID=rs2804402
|Name_s=ABCC2: ?1019a>G
|Gene_s=ABCC2, NANOGP6
|Feature=NA, NA
|Evidence=PubMed ID:19940846
|Annotation=ABCC2*2 (&#8722;1019a>G) is associated with lower irinotecan clearance and with significant reduction in severe diarrhea in cancer patients.
|Drugs=irinotecan
|Drug Classes=
|Diseases=Diarrhea; Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111620
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2804402
|overall_frequency_n=52
|overall_frequency_d=128
|overall_frequency=0.40625
|n_genomes=36
|n_genomes_annotated=0
|n_haplomes=46
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}
{{on chip | 23andMe v3}}